Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
Abstract Attention deficit-hyperactivity disorder (ADHD) is a prevalent neuropsychiatric disorder found in children. It is characterized by inattention, hyperactivity, and impulsivity. Methylphenidate (MPH) and atomoxetine (ATX) are commonly prescribed for the treatment of ADHD. In the present study...
Main Authors: | Shiho Suzuki, Ryo Kimura, Shingo Maegawa, Masatoshi Nakata, Masatoshi Hagiwara |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Molecular Brain |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13041-020-00614-4 |
Similar Items
-
Atomoxetine and Methylphenidate Treatment in ADHD
by: Snircova E., et al.
Published: (2015-05-01) -
Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysis
by: Armagan Aral, et al.
Published: (2022-08-01) -
A critical appraisal of atomoxetine in the management of ADHD
by: Childress AC
Published: (2015-12-01) -
Attention-deficit/hyperactivity disorder
by: A. M.E. du Plessis
Published: (2015-05-01) -
Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report
by: Akın Tahıllıoğlu, et al.
Published: (2021-02-01)